GSK3B and diabetes mellitus: Among the analogues, B29 and B30 with 2-aminopyrimidine substitutions could significantly increase hepatocyte glucose uptake in HepG2 cells, with good inhibitory activity against GSK-3β, showing potential for the treatment of diabetes.